POPULARITY
15 episodes with Resection
26 episodes with Resection
5 episodes with Resection
19 episodes with Resection
18 episodes with Resection
15 episodes with Resection
5 episodes with Resection
5 episodes with Resection
10 episodes with Resection
3 episodes with Resection
5 episodes with Resection
3 episodes with Resection
10 episodes with Resection
4 episodes with Resection
3 episodes with Resection
4 episodes with Resection
3 episodes with Resection
2 episodes with Resection
2 episodes with Resection
3 episodes with Resection
6 episodes with Resection
2 episodes with Resection
6 episodes with Resection
2 episodes with Resection
3 episodes with Resection
2 episodes with Resection
19 episodes with Resection
3 episodes with Resection
2 episodes with Resection
2 episodes with Resection
16 episodes with Resection
2 episodes with Resection
2 episodes with Resection
2 episodes with Resection
2 episodes with Resection
2 episodes with Resection
6 episodes with Resection
6 episodes with Resection
4 episodes with Resection
4 episodes with Resection
3 episodes with Resection
3 episodes with Resection
2 episodes with Resection
2 episodes with Resection
2 episodes with Resection
In this inaugural episode of the Surgical Oncology Insight series of SurgOnc Today®, Dr. Shishir Maithel, Editor of Surgical Oncology Insight, SSO's open-access journal, discusses with Dr. Brett Ecker the results of a systematic review and meta-analysis characterizing the incidence of cfDNA-positivity after resection of colorectal cancer liver metastases with quantification of its sensitivity and specificity for postoperative recurrence, as reported in his article, "The Prognostic Role of Post-operative cfDNA after Resection of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis."
In dieser Folge spreche ich, Christoph Paasch, allein über eine randomisierte Studie aus Belgien. Die Autoren haben den Einfluss des Beckenbodentraining auf das LARS untersucht. Viel Freude beim Hören Christoph Paasch Besprochene Publikation: Asnong A, D'Hoore A, Van Kampen M, Wolthuis A, Van Molhem Y, Van Geluwe B, Devoogdt N, De Groef A, Guler Caamano Fajardo I, Geraerts I. The Role of Pelvic Floor Muscle Training on Low Anterior Resection Syndrome: A Multicenter Randomized Controlled Trial. Ann Surg. 2022 Nov 1;276(5):761-768. doi: 10.1097/SLA.0000000000005632. Epub 2022 Jul 27. PMID: 35894434; PMCID: PMC9534049. Unter folgendem Link können bei der Landesärztekammer Brandenburg 2 Fortbildungspunkte erworben werden. Der Kursinhalt sind stets 3 Folgen. https://lernportal.laekb.de/goto.php?target=crs_3487&client_id=laekb
In this episode recorded during the EAU Robotic Urology Section meeting 2024, Mr. Ben Challacombe (Guy's & St Thomas' MDM Urological Cancer and Clinical Robotics Lead, a UK Robotic Surgery Mentor and Robotic Fellowship Director) spoke to UROONCO RCC Associate Editor Dr. Riccardo Bertolo about robotic resection of renal cell carcinoma recurrence.Mr. Challacombe provided his strategy on how to plan a treatment if the recurrence takes place after partial nephrectomy. He offered insights into the more appropriate treatment (robotic nephron-sparing approach vs. radical nephrectomy vs. ablation) based on the characteristics of the recurrence. He also shared his experiences regarding the status of tissues encountered during such surgeries after the patient is exposed to systemic therapy or radiation. Finally, he shared important insights about the different multi-port and single-port platforms available on the European market, and the choice among them, particularly if such complex surgical interventions must be performed.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, Google Podcasts.
August 23, 2024 Mark, Scott, and Ray talk about two questions that came into the PRS Communities:I have Optum requesting records on all of our clot evac cases where something in the bladder was fulgurated during the same session and after record review we fail the audit.Now compliance is very quick to say refund it, stop billing it, its bundled, etc.But we know a modifier is allowed so when is it allowed????Everything I find online like AAPC says to bill both 52214 and 52001-59 but there is nothing recent and nothing concrete about what is considered distinct. I mean using a clot evacuator is different than using a loop electrode. Below are the Optum rationales.So the urologist does a cysto on hematuria work up, and they wind up using an evacuator to remove huge amounts of clot burden. Then use a loop electrode to fulgurate some areas that look suspicious.Why is that service not considered distinct? Compliance says its incidental but they can't tell me when it wouldn't be incidental and I don't want to let optum take back money without an argument.Hi, I would like to ask a coding question please. Thank you so much!For Robot-assisted left partial nephrectomy and Resection of a left renal hilar lymph node, Do we code any additional CPT to capture renal hilar lymph node, in addition to partial nephrectomy 50543?Pathology report had a separate report for Renal hilar lymph node dissection, which was negative for carcinoma. And for partial nephrectomy, path showed Renal cell carcinoma. PRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a QuoteUrology Advanced Coding and Reimbursement Seminars - In-Person SeminarsRegister Now for the Urology Advanced Coding and Reimbursement SeminarSpecial Early Bird code: 25UACRS732 Click Here for Information and RegistrationEvent DetailsLocation:Las Vegas: December 6-7, 2024, at HorseshoeNew Orleans: January 31-February 1, 2025, at Harrah'sTime: Friday 8 am - 4 pm, Saturday 8 am - 3:30 pmIncludes: Breakfast and Lunch on both days, plus 14 AAPC CEUs The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ Join the discussion:Urology Coding and Reimbursement Group - Join for free and ask your questions, and share your wisdom.Click Here to Start Your Free Trial of AUACodingToday.com
Bardia Nadim, MD discusses a recently published article on the short-term out-of-pocket and total costs of care after ablation, resection, or transplant for early-stage hepatocellular carcinoma, using national SEER-Medicare data. The analysis reveals significant cost differences among these treatments, with ablation being notably less expensive. Dr. Nadeem is joined by Borna E. Dabiri, MD, PhD, who provides insights into the clinical implications, referral processes, post-procedural care, and future research directions. ARTICLE TITLE - Short-Term Out-of-Pocket and Total Costs of Care After Ablation, Resection, or Transplant for Early-Stage Hepatocellular Carcinoma: A National SEER-Medicare Cost Comparison
Dr. Rick Greene discusses with Dr. Brett Ecker the association between extent of resection and disease-specific survival in mucinous and non-mucinous appendiceal adenocarcinomas as reported in his article, "Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and non-Mucinous Histologies.” https://doi.org/10.1245/s10434-024-15233-9
July 12, 2024Scott, Mark, and Dr. Ray Painter are joined by Dr. John Lin. In this episode, they answer two questions that came into the Thriving Urology Practice Facebook group:Pearl:We use 55700 for the MRI fusion prostate biopsy. The docs want to use 55706 instead when MRIfusion biopsy is done with the transperineal approach. Is that OK? Kimberly:Can someone please explain to me if codes 52214 and 52224 can be billed together? If yes, whatmodifier are you using? Also, how is code 52224 a component of 52214??? These codes blow mymind!!!Urology Advanced Coding and Reimbursement VIRTUAL SEMINARRegister Now for the Urology Advanced Codingand Reimbursement Virtual SeminarJoin us on July 27th, 2024, for a live Zoom meeting from 9:30 am to 1:30 pm EST, and master the latest in urology coding and reimbursement with ease.Special Early Bird Discount Code: 24UACRVE7Click Here for Information and RegistrationPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a QuoteUrology Advanced Coding and Reimbursement Seminars - In-Person SeminarsRegister Now for the Urology Advanced Coding and Reimbursement SeminarSpecial Early Bird code: 25UACRS732 Click Here for Information and RegistrationEvent DetailsLocation:Las Vegas: December 6-7, 2024, at HorseshoeNew Orleans: January 31-February 1, 2025, at Harrah'sTime: Friday 8 am - 4 pm, Saturday 8 am - 3:30 pmIncludes: Breakfast and Lunch on both days, plus 14 AAPC CEUs The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ Join the discussion:Urology Coding and Reimbursement Group - Join for free and ask your questions, and share your wisdom.Click Here to Start Your Free Trial of AUACodingToday.com
Ask the Experts: Neuromonitoring for Intramedullary Spinal Cord Tumor Resection Sheng-fu Larry Lo, MD, MHS; Richard Vogel, PhD, DABNM; Adam Doan, DC, DABNM
June 14, 2024Mark, Scott, and Ray discuss topics that came into the PRS communities. Can you bring this back up again as it relates to Audio only calls. Question i have is if you are just reviewing results that were ordered during a visit, this is essentially not a billable event. Isnt it considered double dipping because the review of the results and test order is included when ordered. Aside from the results, going over a treatment plan could be a billable event. Truly depends on what you are using this visit for. I have added an AMA sheet that will help with the different scenarios.Please let me know your thoughts Ordering a test is included in the category of test result(s) and the review of the test result is part of the encounter and not a subsequent encounter.”And, from the CPT Assistant, (AMA publication) November, 2020, page 5: “It is assumed that the physician or other QHP would review the results of the test ordered; therefore, the physician or other QHP would not receive dual credit toward MDM for service-level selection for both ordering and reviewing the test.” Hi, a question please. Thank so much.For Robotic assisted retroperitoneal lymph node dissection, Lap Resection of right gonadal vein/Spermatic cord stump. I coded Robotic assisted retroperitoneal lymph node dissection with 38589 (benchmarked to 38780),but I have a question for Lap Resection of right gonadal vein/Spermatic cord stump,Should these be coded with two CPT codes: One to capture right gonadal vein resection and another one to capture Spermatic cord stump? VS these two are on the same location and should only be coded with one CPT code? Thank you! Urology Advanced Coding and Reimbursement VIRTUAL SEMINARRegister Now for the Urology Advanced Codingand Reimbursement Virtual SeminarJoin us on July 27th, 2024, for a live Zoom meeting from 9:30 am to 1:30 pm EST, and master the latest in urology coding and reimbursement with ease.Special Early Bird Discount Code: 24UACRVE7Click Here for Information and RegistrationPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a QuoteUrology Advanced Coding and Reimbursement Seminars - In-Person SeminarsRegister Now for the Urology Advanced Coding and Reimbursement SeminarSpecial Early Bird code: 25UACRS732 Click Here for Information and RegistrationEvent DetailsLocation:Las Vegas: December 6-7, 2024, at HorseshoeNew Orleans: January 31-February 1, 2025, at Harrah'sTime: Friday 8 am - 4 pm, Saturday 8 am - 3:30 pmIncludes: Breakfast and Lunch on both days, plus 14 AAPC CEUs The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ Join the discussion:Urology Coding and Reimbursement Group - Join for free and ask your questions, and share your wisdom.Click Here to Start Your Free Trial of AUACodingToday.com
Rick Greene, MD, discusses with Lorenzo Ferri, MD, PhD, the long-term survival outcomes of patients with esophageal and junctional adenocarcinoma treated with neoadjuvant docetaxel-based chemotherapy and en bloc transthoracic esophagectomy. Dr. Ferri is author of, "Docetaxel-Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15-Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer Network." Dr. Ferri is Professor of Surgery and Oncology, McGill University; David S. Mulder Chair of Surgery Head, Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre; and, Director, Upper G.I. Cancer Program, McGill University, Montreal, Canada.
Drs. Nicholas Callahan and Michael Miloro discuss the recent JOMS article on nerve reconstruction. The purpose of this study was to evaluate functional sensory recovery of immediate IAN allograft reconstruction performed during ablative mandibular resection at one year following surgery.
Janani S. Reisenauer, MD; Patrick W. Eiken, MD; and Dawn Owen, MD PhD, join journal CHEST Podcast Moderator Dominique Pepper, MD, to discuss new research comparing outcomes for metastasis-directed therapies including sublobar resection, stereotactic body radiation therapy, and percutaneous ablation.
Rick Greene, MD, discusses with Anthony Villano, MD, a review the American College of Surgeons Commission on Cancer Standard 5.6, which pertains to curative intent colon resections performed for cancer. Dr. Villano is author of "Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6." Dr. Villano is the Assistant Professor, Surgical Oncology, in the Department of Surgical Oncology, at Fox Chase Cancer Center in Philadelphia, PA.
We sat down with arguably the world expert on low anterior resection syndrome. Dr. Marylise Boutros (https://twitter.com/BoutrosMarylise) is an academic colorectal surgeon at Cleveland Clinic Florida.. Dr. Boutros talks about her pioneering research to understand and treat the challenging functional issues that patients must content with. We also talk about her move to Cleveland Clinic and her advice for an academic surgical career. Links: 1. Low Anterior Resection Syndrome: Predisposing Factors and Treatment. https://pubmed.ncbi.nlm.nih.gov/34863592/ 2. Low Anterior Resection Syndrome in a Reference North American Sample: Prevalence and Associated Factors. https://pubmed.ncbi.nlm.nih.gov/37466264/ 3. Financial and occupational impact of low anterior resection syndrome in rectal cancer survivors. https://pubmed.ncbi.nlm.nih.gov/33724620/ 4. Assessing the readability, quality and accuracy of online health information for patients with low anterior resection syndrome following surgery for rectal cancer. https://pubmed.ncbi.nlm.nih.gov/30609222/ 5. Comparison of the Colonic J-Pouch Versus Side-To-End Anastomosis Following Low Anterior Resection: A Systematic Review and Meta-Analysis. https://pubmed.ncbi.nlm.nih.gov/37507144/ Bio (from Cleveland Clinic website): Marylise Boutros is a Staff Colorectal Surgeon at the Cleveland Clinic Florida and the Regional Digestive Disease InstituteDirector of Research. Previously, Dr. Boutros was a Colorectal Surgeon at the Jewish General Hospital, Professor of Surgery at McGill University, and Colorectal Surgery Program Director. Having completed General Surgery residency at McGill University and Colorectal Surgery residency at Cleveland Clinic Florida, her clinical interests are advanced minimally invasive approaches to benign and malignant colorectal and anorectal diseases. She treats colon and rectal cancer, inflammatory bowel disease, diverticular disease, fecal incontinence and all anorectal disorders. Dr Boutros is a federally funded researcher who currently leads an internationally renowned research program focused on assessing innovations to improve recovery and functional outcomes after colorectal surgery using multicentre prospective trials, patient-centred interventions and patient-reported outcome measures. Within her research program, Dr Boutros has mentored over forty trainees and graduate students. Dr Boutros also has leadership roles in multiple international societies including Society of American Gastrointestinal and Endoscopic Surgeons, American Society of Colon and Rectal Surgeons, Canadian Society of Colon and Rectal Surgeons and the Canadian Association of General.
Interview with Laura Koskenvuo, MD, PhD, and Ville Sallinen, MD, PhD, authors Morbidity After Mechanical Bowel Preparation and Oral Antibiotics Prior to Rectal Resection: The MOBILE2 Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Morbidity After Mechanical Bowel Preparation and Oral Antibiotics Prior to Rectal Resection
Interview with Laura Koskenvuo, MD, PhD, and Ville Sallinen, MD, PhD, authors Morbidity After Mechanical Bowel Preparation and Oral Antibiotics Prior to Rectal Resection: The MOBILE2 Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Morbidity After Mechanical Bowel Preparation and Oral Antibiotics Prior to Rectal Resection
Rick Greene, MD, discusses with Jean-Nicolas Vauthey, MD, a comparison of different surgical approaches to synchronous liver metastases from rectal cancer and their analysis of both clinicopathological and biological tumor factors associated with completion of the reverse approach. Professor Vauthey is the senior author of, “Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer.” Dr. Vauthey is Professor of Surgery and Chief of the Hepato-Pancreato-Biliary Section, and the Dallas/Fort Worth Living Legend Chair of Cancer Research in the Department of Surgical Oncology at The University of Texas MD Anderson Cancer Center in Houston, TX.
March 8, 2024Mark, Scott, and Ray discuss questions that came into the PRS Network.Hello all, I have a CPT coding question,Indications = Urinary Obstruction // Post-Op DX = Obstruction of neck of Urinary Bladder Resectoscope per urethra into the bladder under direct vision. There was moderate trabeculations with no evidence of mass or stones. The bladder neck was noted to be elevated as seen on prior clinic cystoscopy. This was causing obstruction of the bladder outlet without significant prostatic hypertrophy.The bipolar resectoscope was used with the plasma button attachment to perform a TUIP at 5 o'clock, vaporizing the bladder neck fibers until the bladder neck was able to open properly and drain appropriately. Electrocautery was used for any small bleeding vessels and hemostasis was adequate at the end of the procedure.The recommended Code is: 52450, but the Coder is recommending Code: 52500.We're also taking Codes: 52276 & 52214 into consideration.... Please advise on what you recommend with the Rationale. Any assistance is greatly appreciated.I completed a tapered ureteral reimplant 50783 on the left and a standard Non tapered ureteral reimplant on the right 50780 - does adding LT and RT modifiers allow both codes to be billed as follows:50783 LT50780.51.RT does adding R /L mods address the bundling issue?Coders noting that 50783 includes 50780 -- however this is 2 different sides and can't bill bilateral tapered 50783.50, as only tapered one side, and bilateral reimplant 50780.50 is undercoded for the additional time and complexity of ureteral tapering Has anyone billed for bladder injection of Lipiodol before? I have a provider who resected a large bladder tumor, then injected Lipidol in and around the resection site to aid with the patient's radiation planning for invasive bladder cancer. I was thinking this may be included in the 52240, but the office is suggesting unlisted code 53899 benchmarked to 52287 or 52283. Thoughts? Registration is open for the Documentation for Coding and Reimbursement for APPs Course - Starts 3/11/24Click Here for Information and to JoinPRS Billing and Other ServicesClick Here to Get More Information and Request a Quote The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ Join the discussion:Urology Coding and Reimbursement Group - Join for free and ask your questions, and share your wisdom.Click Here to Start Your Free Trial of AUACodingToday.com
Surgical smoke safety during transurethral resection of the prostate procedures by AORNJournal
Surgical resection of bilateral colorectal liver metastasis (CLM) can pose a significant challenge to even the most experienced HPB surgeon. Is surgical resection justified, if so, in which patients? What's the best surgical approach for curative intent resection of all lesions, and does ablation play a role? In this episode from the HPB team at Behind the Knife, listen in on the discussion about the surgical management of patients with bilateral colorectal liver metastasis. Hosts Anish J. Jain MD (@anishjayjain) is a T32 Research Fellow at the University of Texas MD Anderson Cancer Center within the Department of Surgical Oncology. Timothy E. Newhook MD, FACS (@timnewhook19) is an Assistant Professor within the Department of Surgical Oncology. He is also the associate program director of the HPB fellowship at the University of Texas MD Anderson Cancer Center. Jean-Nicolas Vauthey MD, FACS (@VautheyMD) is Professor of Surgery and Chief of the HPB Section, as well as the Dallas/Fort Worth Living Legend Chair of Cancer Research in the Department of Surgical Oncology at The University of Texas MD Anderson Cancer Center Learning Objectives: · Develop an understanding of patient selection for surgical resection of bilateral colorectal liver metastasis (CLM). · Develop an understanding of the use of Two Stage Hepatectomy (TSH) versus Parenchymal Sparing Hepatectomy (PSH) in the treatment of bilateral CLM. · Develop an understanding of if and when to use ablative procedures for resection of bilateral CLM. · Develop an understanding of selection and management of patients who suffer recurrence after resection of bilateral CLM. Suggested Readings · Omichi K, Shindoh J, Cloyd JM, Mizuno T, Chun YS, Conrad C, Aloia TA, Tzeng CD, Vauthey JN. Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis. Eur J Surg Oncol. 2018 Jan;44(1):122-129. doi: 10.1016/j.ejso.2017.11.006. Epub 2017 Nov 24. PMID: 29208318; PMCID: PMC5742306. https://pubmed.ncbi.nlm.nih.gov/29208318/ · Kawaguchi Y, Kopetz S, Tran Cao HS, Panettieri E, De Bellis M, Nishioka Y, Hwang H, Wang X, Tzeng CD, Chun YS, Aloia TA, Hasegawa K, Guglielmi A, Giuliante F, Vauthey JN. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status. Br J Surg. 2021 Aug 19;108(8):968-975. doi: 10.1093/bjs/znab086. PMID: 33829254; PMCID: PMC8378514. https://pubmed.ncbi.nlm.nih.gov/33829254/ · Nishioka Y, Paez-Arango N, Boettcher FO, Kawaguchi Y, Newhook TE, Chun YS, Tzeng CD, Tran Cao HS, Lee JE, Vreeland TJ, Vauthey JN. Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases. J Gastrointest Surg. 2022 Apr;26(4):791-801. doi: 10.1007/s11605-021-05173-0. Epub 2021 Nov 1. PMID: 34725784. https://pubmed.ncbi.nlm.nih.gov/34725784/ · Passot G, Chun YS, Kopetz SE, Zorzi D, Brudvik KW, Kim BJ, Conrad C, Aloia TA, Vauthey JN. Predictors of Safety and Efficacy of 2-Stage Hepatectomy for Bilateral Colorectal Liver Metastases. J Am Coll Surg. 2016 Jul;223(1):99-108. doi: 10.1016/j.jamcollsurg.2015.12.057. Epub 2016 Jan 18. PMID: 26968325; PMCID: PMC4925205. https://pubmed.ncbi.nlm.nih.gov/26968325/ · Donadon M, Cescon M, Cucchetti A, Cimino M, Costa G, Pesi B, Ercolani G, Pinna AD, Torzilli G. Parenchymal-Sparing Surgery for the Surgical Treatment of Multiple Colorectal Liver Metastases Is a Safer Approach than Major Hepatectomy Not Impairing Patients' Prognosis: A Bi-Institutional Propensity Score-Matched Analysis. Dig Surg. 2018;35(4):342-349. doi: 10.1159/000479336. Epub 2017 Oct 14. PMID: 29032372. https://pubmed.ncbi.nlm.nih.gov/29032372/ · Lillemoe HA, Kawaguchi Y, Passot G, Karagkounis G, Simoneau E, You YN, Mehran RJ, Chun YS, Tzeng CD, Aloia TA, Vauthey JN. Surgical Resection for Recurrence After Two-Stage Hepatectomy for Colorectal Liver Metastases Is Feasible, Is Safe, and Improves Survival. J Gastrointest Surg. 2019 Jan;23(1):84-92. doi: 10.1007/s11605-018-3890-y. Epub 2018 Aug 6. PMID: 30084064; PMCID: PMC6329635. https://pubmed.ncbi.nlm.nih.gov/30084064/ · Panettieri E, Kim BJ, Kawaguchi Y, Ardito F, Mele C, De Rose AM, Vellone M, Chun YS, Tzeng CD, Aloia TA, Giuliante F, Vauthey JN. Survival by Number and Sites of Resections of Recurrence after First Curative Resection of Colorectal Liver Metastases. J Gastrointest Surg. 2022 Dec;26(12):2503-2511. doi: 10.1007/s11605-022-05456-0. Epub 2022 Sep 20. PMID: 36127553. https://pubmed.ncbi.nlm.nih.gov/36127553/ ***Fellowship Application - https://forms.gle/5fbYJ1JXv3ijpgCq9*** Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent Hepatobiliary Surgery episodes here: https://app.behindtheknife.org/podcast-category/hepatobiliary
In this episode of IBD DriveTime, Dr Manasi Agrawal of Mt Sinai Hospital in New York discusses her research into surgery as a first-line therapy for Crohn's disease with host Dr Raymond Cross.
In this episode our team reviews the two groundbreaking RCTs which challenged the long-held dogma that a lobectomy is the only acceptable oncologic procedure for NSCLC. Listen as we compare and contrast the North American CALGB trial and Japanese JCOG trial which were both designed to investigate survival and recurrence outcomes by randomizing stage 1A patients to lobectomy versus a sublobar resection. Learning Objectives: -Compare and contrast the patient characteristics of the CALGB and JCOG trials -Understand the methodology each trial and be able to explain their nuanced differences -Analyze the results of the CALGB and JCOG trials and how they apply to patients today Hosts: Kelly Daus MD, Peter White MD, Eric Vallieres, MD and Brian Louie MD Referenced Material https://pubmed.ncbi.nlm.nih.gov/36780674/ Altorki N, et al. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer. N Engl J Med. 2023 Feb 9;388(6):489-498. doi: 10.1056/NEJMoa2212083. PMID: 36780674; PMCID: PMC10036605. https://pubmed.ncbi.nlm.nih.gov/35461558/' Saji H, et al. West Japan Oncology Group and Japan Clinical Oncology Group. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3. PMID: 35461558. https://pubmed.ncbi.nlm.nih.gov/37473998/ Altorki N, et al. Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance). J Thorac Cardiovasc Surg. 2023 Jul 18:S0022-5223(23)00612-8. doi: 10.1016/j.jtcvs.2023.07.008. Epub ahead of print. PMID: 37473998. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our other Cardiothoracic episodes: https://behindtheknife.org/podcast-category/cardiothoracic/
Doctor Philipp Karschnia (Ludwig-Maximilians-University of Munich, Munich, Germany) discusses the Response Assessment in Neuro Oncology consortium's recommendations on standardised tissue sampling and processing during resection of diffuse intracranial glioma.Read the full Policy Review:https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00453-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanoncContinue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Have you ever heard of an Ovarian Wedge Resection? If you have PCOS, you need to know about it! This long standing procedure is only done by a select few, but it offers incredible results for women with polycystic ovaries. It's intended for women who are both trying to conceive or simply trying to improve their health when dealing with PCOS. Today's episode is with an experienced NaproTechnology Surgical Fellow who has performed this procedure extensively. Dr. Christine Hemphill shares with us what's involved in the procedure, who the ideal candidate is, what concerns to be aware of, and what to expect after surgery. Want to hear MORE from Dr. Hemphill on this topic? We have 10 more minutes of quality show for our subscribers over on Substack. Check it out! Technical note: Please forgive the microphone quality! We made sure it was still easy to listen to and understand, but it does sound different than our normal sound. We should be back to normal next week. Thanks! NOTE: This episode is appropriate for all audiences. SHOW NOTES: Contact Dr. Hemphill's office: 803-438-0825Join our Introductory SessionSchedule a Consultation with Caitlin Get our Monthly Newsletter to get informed & engaged! Charting your Fertility with a Certified FertilityCare Practitioner: Anyone can begin learning more about their reproductive health and how to identify root issues. It is never too late to begin this process! We'd love to help you get started by attending one of our Introductory Sessions - an online, virtual class available each month. Join us! Talk with Caitlin (you do not have to be a client): Need a safe place to talk about your fertility journey, what you're going through (faith, infertility, medical concerns, etc) or anything else about your fertility? Caitlin would love to hear your story and talk with you during a consultation! Support the show
Full article: https://www.ajronline.org/doi/10.2214/AJR.23.29670 Sid Dogra, MD discusses an AJR article in which the authors show that retained biopsy site markers following resection of breast lesions increases risk of residual malignancy, particularly in patients whose initial pathology suggested malignancy. Radiologists can improve patient care by more explicitly noting missing biopsy site markers and recommending early postoperative mammogram on initial intraoperative specimen radiographs.
Prof. Thomas-Gibson shares her perspective on performing high-standard patient care from getting started in Endoscopy, executing high-quality, safe colonoscopies to complication management for EMR and polypectomy. ENDO-1648301-AA
Dr King discusses the need for improved guidance when determining the appropriate management strategy for patients with residual nonretroperitoneal testicular cancer, findings from a study on the association between the presence of teratoma in the primary orchiectomy and the rate of teratoma in this disease, and how the presence or absence of teratoma in the primary tumor should not preclude surgical resection in this population.
Title: Resection/Laser Ablation for Recurrent Glioblastoma Guest faculty: Ricardo J. Komotar, MD, FACS Hosts: Rushna Ali, MD and Seth F. Oliveria, MD PhD
De novo metastatic breast cancer represents 6% of all new breast cancer diagnoses. This figure has not changed at all over the past 20 years; however, systemic therapy options have evolved dramatically during this time and have significantly increased life expectancy for these patients. While surgical management of the primary tumor in the setting of metastatic disease has typically been reserved for palliative indications, surgeons are now being asked to consider resecting the primary tumor to potentially increase overall survival. In this episode, we will use a case study to examine the data that should inform our conversations and decisions when we encounter patients with metastatic breast cancer who are interested in having their primary tumor resected. Links: Khan, S.A., S. Schuetz, and O. Hosseini (2022). Primary-Site Local Therapy for Patients with De Novo Metastatic Breast Cancer: An Educational Review. Ann Surg Oncol; 29: 5811-5820. https://link.springer.com/article/10.1245/s10434-022-11900-x Khan, S.A. et al (2022). Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (E2108). J Clin Oncol; 40(9): 978-987. https://ascopubs.org/doi/10.1200/JCO.21.02006?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Badwe, R. et al (2015). Locoregional treatment versus no treatment of the primary tumor in metastatic breast cancer: an open-label randomized controlled trial. Lancet Oncol; 16: 1380-1388. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(15)00135-7/fulltext Fitzal, F. et al (2019). Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial. Ann Surg; 269(6): 1163-1169. https://journals.lww.com/annalsofsurgery/Abstract/2019/06000/Impact_of_Breast_Surgery_in_Primary_Metastasized.24.aspx Soran, A. et al (2018). Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01. Ann Surg Oncol; 25: 3141-3149. https://link.springer.com/article/10.1245/s10434-018-6494-6 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out other breast surgery episodes here: https://behindtheknife.org/podcast-category/breast/
Interview with Ville Sallinen, MD, PhD, and Alexandre Santos, MD, authors of Quality-of-Life and Recurrence Outcomes Following Laparoscopic Elective Sigmoid Resection vs Conservative Treatment Following Diverticulitis: Prespecified 2-Year Analysis of the LASER Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Quality-of-Life and Recurrence Outcomes Following Laparoscopic Elective Sigmoid Resection vs Conservative Treatment Following Diverticulitis
Interview with Ville Sallinen, MD, PhD, and Alexandre Santos, MD, authors of Quality-of-Life and Recurrence Outcomes Following Laparoscopic Elective Sigmoid Resection vs Conservative Treatment Following Diverticulitis: Prespecified 2-Year Analysis of the LASER Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Quality-of-Life and Recurrence Outcomes Following Laparoscopic Elective Sigmoid Resection vs Conservative Treatment Following Diverticulitis
Rick Greene, MD, discusses with Margaret Kemeny, MD, the results of a phase III randomized trial that evaluated the effect of perioperative fluorouracil on overall survival in for colon cancer. Dr. Kemeny is author of, "Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)." Dr. Kemeny is director of New York's Cancer Center of Excellence at Queens Cancer Center of NYC Health+Hospitals/Queens and Professor of Surgery at at the Icahn School of Medicine at Mount Sinai. http://doi.org/10.1245/S10434-022-12705-8
Join Liz Cruz M.D. and Tina Nunziato, Certified Holistic Nutrition Consultant, as they discuss the colon resection. What it is, who does it and why it gets done. If you have questions about colon resections this podcast is for you!Watch us on YouTube: https://youtu.be/j6RPClywOzgDr. Cruz is a Board Certified Gastroenterologist who practices in Phoenix, AZ. Along with her wife Tina Nunziato, a Certified Holistic Nutritionist, they have helped tens of thousands of individuals get well from a more holistic standpoint. They focus on issues such as constipation, diarrhea, acid reflux, heartburn, gas, bloating, food sensitivities, IBS, Crohn's disease, and diverticulitis in addition to a person's general overall health. They do this by teaching about real food, water, digestive enzymes, probiotics, detox, greens, electrolytes, food sensitivity testing, and so much more. If you're struggling with finding the answers to your issues, tired of not feeling well, and sick of taking over the counter and prescription medicines, schedule a FREE 30 minute phone consult at www.drlizcruz.com.For more information visit www.digestthispodcast.com or www.drlizcruz.com. Enjoy the show! Dr. Liz Cruz and Tina Nunziato, CHNC
Dr. Evan Noch interviews Drs. Richard Drexler and Franz Ricklefs about their recent manuscript entitled: "DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients", published online in Neuro-Oncology in July 2022. Full Report
Title: Radiosurgery versus Surgical Resection for Meningiomas and Schwannomas Guest faculty: Maryam Rahman, MD, MS Moderators: Rushna Ali, MD and Seth F. Oliveria, MD PhD
Second year medical student at Harvard Medical School, Arian Mansur, discusses his research on two different treatment types for lung cancer. The AMA Research Challenge is the largest national, multi-specialty research event for medical students, residents and fellows, and international medical graduates to showcase and present research. Learn more by visiting: https://www.ama-assn.org/about/events/ama-research-challenge
What's the one clinical scenario where you can really save a patient's life with a pancreatectomy? An IPMN with high-grade dysplasia! Join the Behind the Knife HPB Team for a deep dive into the complex decision-making surgical management of IPMNs. Learning Objectives In this episode, we review the basics of intraductal papillary mucinous neoplasms, how to evaluate patients with a cystic mass of the pancreas, guidelines for surveillance, and indications for resection. We discuss key concepts such as Worrisome Features and High-Risk Stigmata and how those influence surgical decision-making, and tackle a few of the most challenging scenarios surgeons may face when treating patients with IPMNs. Hosts: Timothy Vreelant, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center Daniel Nelson, DO, FACS (@usarmydoc24) is an Associate Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at William Beaumont Army Medical Center Connor Chick, MD (@connor_chick) is a PGY-6 General Surgery resident at Brooke Army Medical Center Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a PGY-5 General Surgery resident at Brooke Army Medical Center Beth Carpenter, MD (@elizcarpenter16) is a PGY-4 General Surgery resident at Brooke Army Medical Center Links to Papers Referenced in this Episode Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas Pancreatology. 2017 Sep-Oct;17(5):738-753. https://pubmed.ncbi.nlm.nih.gov/28735806/ Number of Worrisome Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasm. J Am Coll Surg. 2022 Jun 1;234(6):1021-1030. https://pubmed.ncbi.nlm.nih.gov/35703792/ Extent of Surgery and Implications of Transection Margin Status after Resection of IPMNs. Gastroenterology Research and Practice 2014, 1–10. https://pubmed.ncbi.nlm.nih.gov/25276122/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out other Hepatobiliary Surgery episodes here: https://behindtheknife.org/podcast-category/hepatobiliary/
小額贊助支持本節目： https://pay.firstory.me/user/ck4fgb04n698h0804wzdkaycj 簡介： 無論是進行腸道生檢、腸切開還是腸切除 ，腸道傷口關閉都要很精確，因為腸道滲漏會帶來災難性的後果，例如腹膜炎、敗血症和死亡。 降低這種潛在且致命並發症的風險，對於小動物病患胃腸道 (GI) 手術後的整體結果非常重要。 本文的重點討論目前的手術技術，關於小腸腸切除和腸吻合術和術中外科醫生的決策。 ＃腸切除和腸吻合術 (R&A, Resection and anastomosis ) ＃功能性末端對末端吻合釘吻合術 (FEESA, Functional end-to-end stapled anastomosis) ・腸道的手術方式有哪些？ ・腸道縫合的要點？ ・如何選擇腸道縫合的線材？ ・自動訂合裝置該怎麼選擇？ ・正常狗的胃腸道厚度？ ・網膜包裹/漿膜貼片的應用時機？ ・如何進行滲漏測試？ ・腹腔鏡及腹腔鏡輔助的胃腸道手術？ ・如何評估組織的活性？ 重點整理：https://wp.me/p9soeV-L4 留言告訴我你對這一集的想法： https://open.firstory.me/user/ck4fgb04n698h0804wzdkaycj/comments Powered by Firstory Hosting
We're back with the second episode of our image guided surgery video series! In the second part of this episode we're discussing lung nodule resection in hybrid OR with some of our Interventional Radiology and Pediatric Surgery colleagues at Cincinnati Children's Hospital. Our guests are Dr. Anusua "Roshni" Dasgupta, Dr. John Racadio, Dr. Neil Johnson and Nicole Hilvert. And we're joined by Dr. Denise Liu, radiology resident at University of Toledo. Hosts: Rod Gerardo, MD, Em Tombash, MD With image guided surgery, surgeon uses real-time images of the inside of the body during an operation. These images are generally produced by a combination of X-rays, ultrasound, CT's etc. Hybrid OR (operating room) at Cincinnati Children's is a collaboration between Radiology's Dr. John Racadio and Surgeon-in-Chief Dr. Daniel von Allmen. The hybrid OR offers imaging capabilities in a sterile operating room. It creates an environment for surgeons and interventional radiologists to combine their individual skills and expertise in order to benefit patient care. The room is equipped with X-ray, fluoroscopy (live X-ray), ultrasound and C-arm Cone Beam computed tomography (CBCT). Surgeons work together in the hybrid OR with interventional radiologists, who specialize in using these imaging technologies. Imaging can be performed just before the surgery to help plan the procedure, during the surgery to identify important anatomy or disease, and after the surgery to evaluate results in the hybrid OR. Any surgery requiring radiologic imaging including open and minimally invasive surgeries, may take place in the hybrid OR. The hybrid OR at Cincinnati Children's opened in 2018 and serves for general surgery, urology, orthopedic surgery, neurosurgery, pulmonology, and many more. Don't forget to like and subscribe to see more entertaining medical educational videos! Follow StayCurrent MD on social media! Instagram: www.instagram.com/staycurrentmd/ Twitter: www.twitter.com/StayCurrentMD Facebook: www.facebook.com/staycurrentsurgery Don't forget to like and subscribe to see more entertaining medical educational videos! See more lectures, articles, and more on the Stay Current app: https://www.globalcastmd.com/stay-current-app-download
We're back with the second episode of our image guided surgery video series! In the first part of this episode we're discussing long nodule localization in hybrid OR with some of our Interventional Radiology and Pediatric Surgery colleagues at Cincinnati Children's Hospital. Our guests are Dr. Anusua "Roshni" Dasgupta, Dr. John Racadio, Dr. Neil Johnson and Nicole Hilvert. And we're joined by Dr. Denise Liu, radiology resident at University of Toledo. Hosts: Rod Gerardo, MD, Em Tombash, MD
The finale of our third season of Delta Green -- No spoilers here! Get a copy here: shop.arcdream.com/ Follow us! --FB: bit.ly/MindPlayersFB --Insta: bit.ly/MindPlayersIG --Twitter: bit.ly/MindPlayersTw --Twitch: bit.ly/MindplayersTwitch --YouTube: bit.ly/MindPlayersYT --Patreon: bit.ly/MindPlayersPat Music Attribution: Theme, Creeper, Exandroid, Sasha-rosser – Creeper Backing tracks: Nicolas Jeudy / DARK FANTASY STUDIOThe T Cell heads to Arkham to follow some of their leads; will they find themselves deeper in the mire than they were hoping?
The T Cell finally uncovers the truth behind El Cacao. Get a copy here: shop.arcdream.com/ Follow us! --FB: bit.ly/MindPlayersFB --Insta: bit.ly/MindPlayersIG --Twitter: bit.ly/MindPlayersTw --Twitch: bit.ly/MindplayersTwitch --YouTube: bit.ly/MindPlayersYT --Patreon: bit.ly/MindPlayersPat Music Attribution: Theme, Creeper, Exandroid, Sasha-rosser – Creeper Backing tracks: Nicolas Jeudy / DARK FANTASY STUDIOThe T Cell heads to Arkham to follow some of their leads; will they find themselves deeper in the mire than they were hoping?
The T Cell uncovers a supernatural force that they did not expect; will they make it through the trial? Get a copy here: shop.arcdream.com/ Follow us! --FB: bit.ly/MindPlayersFB --Insta: bit.ly/MindPlayersIG --Twitter: bit.ly/MindPlayersTw --Twitch: bit.ly/MindplayersTwitch --YouTube: bit.ly/MindPlayersYT --Patreon: bit.ly/MindPlayersPat Music Attribution: Theme, Creeper, Exandroid, Sasha-rosser – Creeper Backing tracks: Nicolas Jeudy / DARK FANTASY STUDIOThe T Cell heads to Arkham to follow some of their leads; will they find themselves deeper in the mire than they were hoping?
The T Cell begin to uncover what really happened to Kyle Woodson's expedition Get a copy here: shop.arcdream.com/ Follow us! --FB: bit.ly/MindPlayersFB --Insta: bit.ly/MindPlayersIG --Twitter: bit.ly/MindPlayersTw --Twitch: bit.ly/MindplayersTwitch --YouTube: bit.ly/MindPlayersYT --Patreon: bit.ly/MindPlayersPat Music Attribution: Theme, Creeper, Exandroid, Sasha-rosser – Creeper Backing tracks: Nicolas Jeudy / DARK FANTASY STUDIOThe T Cell heads to Arkham to follow some of their leads; will they find themselves deeper in the mire than they were hoping?
The T Cell finally arrive in Belize where they meet up with an old acquaintance and try to assess the situation. Get a copy here: shop.arcdream.com/ Follow us! --FB: bit.ly/MindPlayersFB --Insta: bit.ly/MindPlayersIG --Twitter: bit.ly/MindPlayersTw --Twitch: bit.ly/MindplayersTwitch --YouTube: bit.ly/MindPlayersYT --Patreon: bit.ly/MindPlayersPat Music Attribution: Theme, Creeper, Exandroid, Sasha-rosser – Creeper Backing tracks: Nicolas Jeudy / DARK FANTASY STUDIOThe T Cell heads to Arkham to follow some of their leads; will they find themselves deeper in the mire than they were hoping?
After a close run-in with the local authorities, the T Cell must push forward with their investigation. Get a copy here: shop.arcdream.com/ Follow us! --FB: bit.ly/MindPlayersFB --Insta: bit.ly/MindPlayersIG --Twitter: bit.ly/MindPlayersTw --Twitch: bit.ly/MindplayersTwitch --YouTube: bit.ly/MindPlayersYT --Patreon: bit.ly/MindPlayersPat Music Attribution: Theme, Creeper, Exandroid, Sasha-rosser – Creeper Backing tracks: Nicolas Jeudy / DARK FANTASY STUDIOThe T Cell heads to Arkham to follow some of their leads; will they find themselves deeper in the mire than they were hoping?
© 2020-2025 Ivy Podcast Discovery LLC
